Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic

NCT04927221 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: DC371739 Tablets
DRUG: Placebo

Sponsor

Guangzhou JOYO Pharma Co., Ltd

Collaborators

[object Object]